Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML

Name: Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML
Published: 2006
License: Public Domain

University Hospital Muenster · 2006

ClinicalTrials.gov · Datasets · License: Public Domain · 2006

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, sorafenib, flt3, aml, kinase inhibitor, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML

Related documents